SCHEMBL8796491

SCHEMBL8796491

CC1(C)CCC(C)(C)c2cc(/C=C(\CO[Si](C)(C)C(C)(C)C)c3cccc(Br)c3)ccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARG P13631 12/20 0.38
RARA P10276 12/20 0.38
RARB P10826 11/20 0.38
RXRA P19793 8/20 0.38
CYP26A1 O43174 3/20 0.34
CYP3A4 P08684 3/20 0.34
PLA2G4A P47712 2/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
NPC1 O15118 1/20 0.34
GMNN O75496 1/20 0.34
USP2 O75604 1/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
CYP1A2 P05177 1/20 0.34
POLB P06746 1/20 0.34
CYP2D6 P10635 1/20 0.34
NFKB1 P19838 1/20 0.34
CYP2C19 P33261 1/20 0.34
THPO P40225 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8796493 1.00 RARG (0.38) RARGRARARARBRXRACYP26A1
SCHEMBL8795779 0.92 PLA2G4A (0.44) RARGRARARARBRXRAPLA2G4A
SCHEMBL8795773 0.92 PLA2G4A (0.44) RARGRARARARBRXRAPLA2G4A
SCHEMBL8796246 0.86 RARA (0.41) RARGRARARARBRXRACYP26A1
SCHEMBL8796237 0.86 RARA (0.41) RARGRARARARBRXRACYP26A1
SCHEMBL8796232 0.84 RXRA (0.39) RARGRARARARBRXRACYP26A1
SCHEMBL8796507 0.83 PLA2G4A (0.39) RARGRARARARBRXRACYP26A1
SCHEMBL8796517 0.83 PLA2G4A (0.39) RARGRARARARBRXRACYP26A1
SCHEMBL8795690 0.81 KMT2A (0.36) CYP3A4KDM4ENPC1CYP1A2CYP2D6
SCHEMBL8795878 0.81 RARB (0.45) RARGRARARARBRXRACYP26A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0799224-A1 NOVEL QUINOXALINES AND DRUGS PREPARED THEREFROM BASF AKTIENGESELLSCHAFT (DE) 1997-10-08 EP disclosed
EP-0629604-B1 Alicyclic phospholipase A2 inhibitors BRISTOL MYERS SQUIBB CO (US) 1997-04-16 EP disclosed
US-5436369-A Alicyclic phospholipase A2 inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1995-07-25 US disclosed
EP-0629604-A2 Alicyclic phospholipase A2 inhibitors Bristol-Myers Company (US) 1994-12-21 EP disclosed